Bruce S. Rosenbloom Sells 1,500 Shares of PetMed Express Inc. (PETS) Stock
PetMed Express Inc. (NASDAQ:PETS) insider Bruce S. Rosenbloom sold 1,500 shares of the firm’s stock in a transaction on Monday, October 10th. The shares were sold at an average price of $21.00, for a total transaction of $31,500.00. Following the sale, the insider now owns 41,767 shares in the company, valued at $877,107. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
Shares of PetMed Express Inc. (NASDAQ:PETS) opened at 20.49 on Friday. The company has a market capitalization of $413.49 million, a P/E ratio of 19.51 and a beta of 1.07. PetMed Express Inc. has a one year low of $15.61 and a one year high of $21.16. The firm has a 50-day moving average of $20.42 and a 200-day moving average of $19.30.
PetMed Express (NASDAQ:PETS) last issued its quarterly earnings results on Monday, July 25th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.31 by $0.01. PetMed Express had a net margin of 9.09% and a return on equity of 25.97%. The business had revenue of $72.50 million for the quarter. During the same quarter in the previous year, the company posted $0.29 EPS. The company’s revenue for the quarter was up 1.3% compared to the same quarter last year. Analysts forecast that PetMed Express Inc. will post $1.11 earnings per share for the current year.
A number of hedge funds and other institutional investors have recently modified their holdings of PETS. NEXT Financial Group Inc raised its position in shares of PetMed Express by 167.2% in the second quarter. NEXT Financial Group Inc now owns 5,354 shares of the company’s stock worth $100,000 after buying an additional 3,350 shares during the last quarter. BNP Paribas Arbitrage SA raised its position in shares of PetMed Express by 101.2% in the second quarter. BNP Paribas Arbitrage SA now owns 6,206 shares of the company’s stock worth $116,000 after buying an additional 3,121 shares during the last quarter. Royal Bank of Canada raised its position in shares of PetMed Express by 19.6% in the second quarter. Royal Bank of Canada now owns 6,423 shares of the company’s stock worth $120,000 after buying an additional 1,053 shares during the last quarter. Cutler Group LP raised its position in shares of PetMed Express by 832.0% in the second quarter. Cutler Group LP now owns 7,064 shares of the company’s stock worth $132,000 after buying an additional 8,029 shares during the last quarter. Finally, Bank of Montreal Can bought a new position in shares of PetMed Express during the second quarter worth about $143,000. Institutional investors and hedge funds own 75.97% of the company’s stock.
PETS has been the topic of several recent analyst reports. Zacks Investment Research downgraded shares of PetMed Express from a “buy” rating to a “hold” rating in a research report on Tuesday, September 27th. Credit Suisse Group AG restated a “sell” rating and set a $13.00 price objective on shares of PetMed Express in a research report on Tuesday, August 16th.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.